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Abstract
Embryonic stem cells (ESC) need a set of specific factors to be propagated. They can also grow in conditioned
medium (CM) derived from a bovine granulosa cell line BGC (BGC-CM), a medium that not only preserves their main
features but also increases ESC´s proliferation rate. The mitogenic properties of this medium were previously
reported, ascribing this effect to an alternative spliced generated fibronectin isoform that contains the extra domain A
(FN EDA+). Here, we investigated if the FN EDA+ isoform increased proliferation of mouse and human ES cells. We
analyzed cell proliferation using conditioned media produced by different mouse embryonic fibroblast (MEF) lines
genetically engineered to express FN constitutively including or excluding the EDA domain (FN EDA-), and in media
supplemented with recombinant peptides containing or not the EDA. We found that the presence of EDA in the
medium increased mouse and human ESC’s proliferation rate. Here we showed for the first time that this FN isoform
enhances ESC’s proliferation. These findings suggest a possible conserved behavior for regulation of ES cells
proliferation by this FN isoform and could contribute to improve their culturing conditions both for research and cell
therapy.
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Introduction
Embryonic stem cells (ESC) are derived from the inner cell
mass of blastocysts and have the potential to give rise to all
cell types of the body. This property, named pluripotency, is
restricted only to a few types of stem cells. Pluripotent cells
provide a powerful model to investigate molecular and cellular
processes involved in lineage-specification and
embryogenesis, to perform drug screening, and to assess
potential applications in the field of tissue engineering and cell
therapy.
Many factors and signaling pathways affect pluripotent stem
cells’ proliferation, like MAPK, phosphoinositide 3-kinase [1,2]
and glycogen synthase kinase 3 pathways [3], mTor [4], BMP-4
and Wnt1 [5], brain natriuretic peptide signaling [6], among
others. Culture conditions like seeding density [7], oxidative
stress [8] and nutrient availability, also influence stem cell
propagation. It has been reported that high glucose
concentrations present in the culture medium induce fibronectin
(FN) expression in mESC, and that this molecule could be
responsible for the augmented proliferation in response to the
high glucose concentrations [9,10].
We have recently shown that conditioned medium (CM) from
a bovine granulosa cell line (BGC-CM) is able to maintain
mouse pluripotent stem cells’ self-renewal, including ESC and
induced pluripotent stem cells (iPSC), while preserving their
unique properties, in culture without Leukemia Inhibitor Factor
(LIF) addition [11,12]. Pluripotent stem cells growing on BGC-
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CM expressed stem cell markers and remained pluripotent.
Moreover, we also found that mES cells cultured in these
conditions have an increased proliferation rate compared with
cells cultured in ESC standard proliferation medium (PM) [12].
The conditioner cell line was previously established [13] and
formerly selected by its mitogenic properties on the same
granulosa cell line and on primary cultures [14]. It was reported
that a form of FN that alternatively includes spliced domain A
(EDA) (FN EDA+) present in the above mentioned CM, could
be responsible for the mitogenic effect. The authors showed
that FN-depleted conditioned medium did not exhibit
proliferation stimulatory effect on granulosa cells, and that
supplementation of this CM with plasma FN, which lacks exon
EDA, had also no effect on cells mitogenic properties [15]. It is
worth mentioning that FN EDA+ is usually expressed in
proliferating tissues, suggesting that this isoform may play a
role in cell proliferation [15–18]. Moreover, it was shown that
EDA inclusion potentiated the ability of FN to promote cell cycle
progression [19].
Considering all these evidences, in this work we studied the
effect of FN EDA+ on ESC proliferation. We found that this
specific isoform is capable of augmenting the mitogenic
capabilities of both mouse and human ES cells. These findings
suggest a possible conserved mechanism for regulation of ES
cells proliferation by this FN isoform.
Materials and Methods
Cell culture
The E14-derived Ainv15 and R1 mESC lines were obtained
from ATCC and cultured as previously described [11,12,20].
The human embryonic stem cell (hESC) line WAO9 was
purchased from WiCell Research Institute, and the hESC line
HUES-5 was acquired from Harvard University and the Howard
Hughes Medical Institute at low passages (p15 to p20) [21].
The hESC lines were maintained on a mitotically inactivated
MEF feeder layer in medium comprised of Dulbecco's Modified
Eagle's Medium/Ham's F12 supplemented with KSR 20% 2
mM nonessential amino acids, 2 mM L-glutamine, 100 U/ml
penicillin, 50 μg/ml streptomycin, 0.1 mM β-mercaptoethanol
and 4 ng/ ml of bFGF on diluted (1/40) MatrigelTM coated dishes
in MEF conditioned medium. For the conditioning medium,
3×106 inactivated MEF cells were incubated for 24 h with 25 ml
of DMEM/F12 medium supplemented with 5% KSR and 2
ng/ml of bFGF (in addition to the other aforementioned
supplements) and stored at -20 °C. After thawing, fresh
aliquots of KSR and bFGF were added to the medium to render
a final concentration of 20% and 4 ng/ml, respectively. In vitro
differentiation protocol was performed as previously described
[22] from ES cells cultured on Matrigel for three days in the
presence or absence of exogenous EDA.
Conditioned Media obtention
MEF were prepared from EDAwt/wt, EDA+/+, and EDA-/-
animals, described previously [23]. Briefly, MEF were obtained
from 13.5 days embryos, and propagated at high density in
DMEM high glucose supplemented with 10% FBS (GIBCO),
glutamine, and antibiotics for successive passages until MEF
cell lines were established. Then, MEF cell lines were cultured
in the same culture medium to 80% confluence. Culture
medium was replaced by fresh medium, and incubated for 24
hours. After incubation, conditioned medium was removed,
centrifuged at 2,000 x g during 10 minutes and supplemented
with LIF, 5% FBS, nonessential amino acids and 0.5 mM beta-
mercaptoethanol before use.
Cell proliferation assay
In proliferation assays, ES cells were plated on feeder free
conditions. Human ES cells were plated on Matrigel coated
plates with MEF conditioned medium and mouse ES cells on
gelatin coated plates with standard proliferation medium with
LIF. Twenty four hours later, the media were replaced by the
corresponding medium for each experimental condition.
For crystal violet or MTT assays, mouse ES cells were
seeded in a flat bottom 96-well plate. For each experiment,
3,000 cells per well were seeded on gelatin coated plates in
standard proliferation medium. 24 hours later, the medium was
removed and replaced by the corresponding medium. Cell
proliferation was quantified by the MTT method (SIGMA) or by
crystal violet staining (Anedra), according to manufacturer’s
instructions. Briefly, for MTT method, culture media were
prepared without phenol red. A volume of MTT solution equal
to 20% of culture medium was added 3 hours prior to
measurement. Formation of colored product, the orange
formazan derivative, was quantified collecting the culture
medium, reading its absorbance at 450 nm and subtracting
background contribution from the reactive sodium salt of MTT,
at 690 nm in a multiwell plate reader (Microplate Reader,
BioRad model 680). An initial measurement was taken 3 hours
after seeding cells in the plate. Afterwards, absorbance at 450
and 690 nm was measured once a day during at least 5 days.
In order to assess cell proliferation rate, corrected absorbance
vs. time were graphed and slopes for each culture medium
were then compared. For crystal violet staining, cells were
rinsed twice with ice-cold PBS and then fixed with methanol for
10 minutes at -20 °C. Staining was carried out with 0.5 %
crystal violet in methanol for 10 minutes and then washed with
water until the dye was completely removed. Plates were let
dry at room temperature and crystal violet was solubilized with
10 % acetic acid. Absorbance was measured at 590-595 nm.
For the wound healing assay, hES cells were plated on
Matrigel coated plates with MEF conditioned medium. After
24-48 hours, a “wound gap” was created in the center of the
hESC’s colonies by scratch or aspiration of the cells with a 200
μl pipet tip. The cells were rinsed with PBS and the media was
replaced by fresh MEF conditioned medium containing or not
the indicated peptides. The healing was monitored by
microphotograph every day. The images were analyzed with
the ImageJ software (ImageJ 1.44p, Wayne Rasband, National
Institutes of Health, USA. http://imagej.nih.gov/ij, Java 1.6.0_20
(32-bit).
To study Bromodeoxy Uridine (BrdU) incorporation, BrdU
immunostaining was used to identify proliferating cells. After 72
hours of treatment as indicated, the samples were pulsed with
100 μM BrdU in the corresponding medium for 30 minutes or
15 minutes for human or mouse ES cells, respectively; fixed in
EDA Fibronectin Increases ESC's Proliferation
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4% paraformaldehyde for 30 minutes, and permeabilized with
0.5% Triton X-100 for 10 min or 10 minutes in methanol -20 °C,
respectively. Samples were then incubated in 2 M HCl for 30
minutes at 37°C, and then washed in PBS containing 0.2%
Tween 20. The samples were incubated overnight at 4°C with
primary antibody against BrdU (GE Healthcare, Cat. RPN202),
washed with PBS and then were incubated during 1 hour with
the secondary antibody (anti-mousse IgG FITC, Sigma, #
F0257) and DAPI. Then, the samples were washed with PBS,
mounted in Mowiol (Calbiochem, Cat# 475904) and take
microscope images in an Olympus IX71 fluorescence
microscope. For Ki67, the same immunostaining protocol was
used without the HCl incubation. The primary antibody was
Novocastra Leica: NCL-L-Ki67-MM1.
Production of EDA-containing and EDA-lacking
recombinant peptides
EDA-containing and EDA-lacking recombinant peptides were
obtained as described [24]. Briefly, we used the previously
BL21 E. coli competent cells transfected with 804 bp containing
the EDA segment flanked by the 11th and 12th type III repeats,
or 534 bp lacking the EDA domain cloned in the BamHI site of
the pProEX Htb expression vector. Peptides expression was
induced by addition of isopropyl-β-D-1-thiogalactopyranoside to
a final concentration of 1 mM. Cells were then lysed and
disrupted by freezing/thawing and sonicated in a BRANSON -
Fisher Scientific Model 500 sonicator, 8 pulses of 10 seconds
at 15% amplitude, with 10 seconds intervals, on ice. Protein
extracts were loaded on a 12% SDS-PAGE gel. Bands
corresponding to the EDA-containing and EDA-lacking
peptides were detected by staining the gel with 1 M KCl, cut
out from the gel and electroeluted in 50 mM carbonate-
bicarbonate buffer, pH 9.6, during 3 hours at 150 mA in a
benzoylated dialysis tubing with a 2000 MW pore size (Sigma,
D-2272). Protein concentration was determined by Bradford
Protein Assay. We performed a dose-response curve to
determine the most effective dose (Figure S1). We observed a
dose-dependent effect in the mES cells proliferation rate. Then,
we selected the dose named “dilution 1”, corresponding to 10
µg of proteins per ml of medium, to perform the next series of
experiments. All the experiments were performed with the
same batch for each peptide.
Statistical analysis
An unpaired t-test for unequal variances was applied to
determine differences between proliferation levels of ES cells in
the presence of EDA+/+ MEF-CM or EDA-/- MEF-CM. Normality
was assessed by Shapiro-Wilk test. A One way ANOVA was
used to determine differences between proliferation levels of
ES cells in the presence of medium supplemented with EDA-
containing or EDA-lacking recombinant peptides for 2 and 3
days. Normality was assessed as mentioned before and
variance homogeneity assumption was assessed by Levene
test. Whenever those assumptions were not accomplished,
data were transformed. In all cases, statistical significance was
assumed when P ≤ 0.05. A Chi Square test was used to
compare the number of positive Ki67 cells and positive BrdU
cells between control and each treatment. Bonferroni´s method
was used to correct p values for multiple comparisons. The
data were analysed using SPSS version 17 (SPSS Inc,
Chicago, IL).
Teratoma formation assay
Teratoma formation assay and analysis was performed as
previously described [12] from Ainv15 mouse ES cells cultured
for three days on gelatin coated plates in the presence or not of
exogenous EDA.
Reverse transcription-polymerase chain reaction
RT-PCR were performed and analyzed as previously
described. Primer sequences were supplied in the same
references 11,12,20, except for mouse and human FN EDA+
and human Cardiac Troponin, that are indicated in Table S1.
Results
We previously reported that conditioned medium (CM) from a
bovine granulosa cell line (BGC-CM) is able to maintain mES
cells’ and iPSCs’ self-renewal and pluripotency. Moreover,
BGC-CM increased their proliferation rate [12]. Based on
evidences involving FN EDA+ as the factor present in BGC-CM
responsible for the increased proliferation in granulosa cells
[15], we hypothesized that this FN isoform might also be
mitogenic for ES cells.
To test this possibility, we reasoned that addition of the FN
EDA+ isoform to the culture medium should mimic the
mitogenic effects of BGC-CM. To this end, we cultured the
E14-derived ESC line, Ainv15, in different culture contexts
providing the two different FN variants, FN EDA+ or FN EDA-,
and then studied ESC’s proliferation by crystal violet staining or
MTT assay. For this analysis we designed two different
experimental approaches.
In the first approach, we cultured mES cells in the presence
of media conditioned by three different MEF lines. Two of them
were obtained from genetically modified mice, whose FN genes
were engineered to express only one of the FN isoforms
respect to EDA inclusion [23]. EDA+/+ mice have optimized 5’
and 3’ EDA splicing sites and, thus, generate FN mRNA with
constitutively included EDA exon [25]. On the contrary, EDA-/-
mice have the EDA exon deleted and produce FN mRNA
constitutively lacking it [23]. We also used MEF from wild type
mice as a control. Therefore, the media conditioned by these
different MEF lines (MEF-CM) are expected to contain different
FN isoforms. MEF derived from EDA-/- mice express solely the
FN isoform that excludes EDA (FN EDA-), wild type MEF
produces both forms, 60% EDA+, 40% EDA-, approximately
[23], and the EDA+/+ MEF line expresses only the isoform that
includes EDA [23,24]. The cells were plated on feeder free
gelatin coated plates in the standard proliferation medium and
24 hours later, when the cells were attached, the medium was
changed. Colony morphology and proliferation were monitored
daily. As shown in Figure 1, when the mESC were cultured in
EDA-/- MEF-CM, their proliferation rate was considerably lower
than when they were propagated in wt MEF-CM or in EDA+/+
MEF-CM. Although we didn´t find important differences in the
proliferation rate of mES cells when cultured with wt MEF-CM
EDA Fibronectin Increases ESC's Proliferation
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and in EDA+/+MEF-CM, we noticed a trend showing a slight
increase in the proliferation rate of the latter. When comparing
proliferation rate between ES cells cultured in EDA+/+ MEF-CM
or EDA-/- MEF-CM we found significantly differences. These
results suggest that the FN EDA+ present in the conditioned
media is a mitogenic factor for ESC.
To confirm these results and further determine whether the
EDA segment was capable of increasing ESC’s proliferation
rate, we next assessed ESC’s proliferation in standard
proliferation medium supplemented with recombinant peptides
containing or not the EDA [24]. We first performed a pilot
experiment to determine the most effective dose, as described
in Materials and Methods section (Figure S1). mESC were
cultured for 48 or 72 hours in proliferation medium
supplemented with recombinant peptides containing or not the
EDA. As shown in Figure 2, ES cells’ proliferation rate
augmented significantly more in the presence of EDA+ peptide
than in the presence of EDA- peptide. No significant differences
were detected between untreated cells and cells treated with
EDA- peptide, at 48 hours. The proliferation rate of cells
supplemented with the EDA+ peptide was significantly higher
than cells that were supplemented with EDA- or no peptide.
This difference was even higher at 72 hours.
Figure 1.  MEF conditioned medium that contains FN EDA+ increases the proliferation rate of mESC.  Ainv15 mES cells were
cultured in the media conditioned by wild type MEF (wt), EDA+/+ MEF (+/+) or EDA-/- MEF (-/-) for 2 days. The proliferation was
evaluated by MTT assay. A representative experiment of at least three replicates is shown. Bars represent mean ± SD. Statistical
analysis was done by an unpaired t-test. * indicate significant differences between treatments (P < 0.01).
doi: 10.1371/journal.pone.0080681.g001
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To further confirm these results, we analyzed BrdU
incorporation, a structural analogue of nucleotide Thymidine
that is incorporated into DNA during its replication in actively
proliferating cells. We compared the number of BrdU positive
cells among untreated or EDA-treated mES cells. In this
experiment, we cultured mES cells in the presence of EDA+
peptide or in EDA+/+ MEF-CM. As shown in Table 1, EDA
treatment increased the number of BrdU positive cells.
Figure 2.  EDA+ but not EDA- peptide increases the proliferation rate of mESC.  (A) Ainv 15 mouse ES cells were cultured in
the standard media supplemented by the corresponding peptide preparation to a final dose of 10 µg of protein per ml of medium for
72 hours. (EDA-containing recombinant peptide, EDA+; EDA-lacking recombinant peptide, EDA-). Representative brightfield pictures
are shown. Bars correspond to 50 µm. (B) The proliferation of Ainv15 mES cells cultured in the media described in B for 48 or 72
hours, as indicated, was evaluated by crystal violet. A representative experiment of at least three replicates is shown. Bars
represent mean ± SD. Statistical analysis was done by One way ANOVA with Bonferroni test for multiple comparisons. * indicate
significant differences between treatments (P < 0.05); ** indicate significant differences between treatments (P < 0.005).
doi: 10.1371/journal.pone.0080681.g002
Table 1. Analysis of BrdU incorporation in Ainv 15 mES cells in different media conditions.
 Positive BrdU cells (%) N(1) p value(2)
Control 58,70 477  
EDA+/+ MEF-CM 68,84 337 0.01
FN EDA+ Peptide 87,69 463 <0.001
(1) Number of total cells positive for DAPI staining (2) p values resulted from comparison of each treatment with the control. A Chi Square test was used to compare the
number of positive BrdU cells between control and each treatment. Bonferroni´s method was used to correct p values for multiple comparisons. Control: untreated cells.
Values correspond to a representative experiment with three biological replicates.
doi: 10.1371/journal.pone.0080681.t001
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As a whole, these results demonstrate that FN EDA+, both
secreted by MEF lines or added to the medium as recombinant
peptide, increases the proliferation rate of mES cells.
To extend our analyses, we finally studied the effect of EDA+
and EDA- peptides on WAO9 human ES cells. We first
analyzed cell proliferation by two different modalities of the
wound-healing assay: by performing a linear or a circular
wound to the monolayer [26,27] and supplementing the culture
medium with the recombinant peptides used above. As shown
in Figure 3, cells that were treated with EDA+ peptide covered
the damaged area faster than cells that were cultured in the
presence of EDA- peptide or that in the control without any
addition. Similar results were obtained in HUES 5 hESC line
(Figure S2).
Since the wound healing rate could be the consequence of
cell migration, besides proliferation, we next quantified
proliferation rates by measuring incorporation of BrdU (Table
2). We also measured the proliferation marker nuclear antigen
Ki67 (Table 3). Both treatments, medium supplemented with
EDA+ peptide and EDA+/+MEF-CM increased BrdU
incorporation and the percentage of Ki67 positive cells with
respect to untreated cells, which were cultured on MEF
conditioned medium. These results indicate that EDA increases
proliferation rate in the human embryonic stem cell line WAO9.
In summary, we found that ESC cultured with CM containing
EDA+FN or recombinant peptides containing the EDA show a
higher proliferation rate than ESC supplemented with CM from
EDA-MEFs or peptides lacking the EDA. This effect was
observed in mouse and human ESC lines, as determined by
different experimental approaches. In fact, we observed the
same effect in Ainv15 mESC line, detected by MTT or crystal
violet at different days of treatment, and in WAO9 hESC line,
detected by the wound healing assay, BrdU incorporation and
Ki67 staining.
Finally, we wondered if ES cells treated with EDA containing
FN preserved their basic properties. We evaluated both self-
renewal and pluripotency on ES cells cultured for three days in
the presence of exogenous EDA. We found that EDA treated-
ES cells expressed pluripotency markers Oct4, Sox2 and
Nanog (Figure 4). Futhermore, these cells remained
pluripotent, as they gave raise to cells deriving from the three
germ layers, evidenced by an in vitro differentiation protocol
and teratoma assay, in human ES cells and mouse ES cells,
respectively. (Figure 5 and Figure 6).
Discussion
Extracellular matrix components interact with
transmembrane cellular receptors belonging to the integrin
family and stimulate cell proliferation. One of these extracellular
matrix proteins, FN, is highly efficient in cell cycle progression
stimulation [28–30]. Until recently, the mechanisms involved in
the effect of FN and FN isoforms on stem cells proliferation had
not been studied. FN expression in mouse ES cells is
modulated by glucose levels in the culture medium and it was
suggested that the increased FN synthesis was responsible for
the augmented proliferation in response to high glucose
concentrations [9]. It was also reported that hypoxia increases
proliferation of mES cells via FN and β1 Integrin induction [31].
Unfortunately, a more detailed analysis addressing the FN
isoforms involved was not yet performed. Here, we more finely
studied the effects on ES cells proliferation of FN addition by
determining the FN isoform involved. In fact, we showed that
the increase in ESC proliferation rate caused by the addition of
FN containing the EDA, an isoform present in embryos and in
actively duplicating tissues, was significantly higher than that
observed after the addition of FN lacking the EDA, an isoform
identical to pFN, which is commonly used as FN source.
It was also shown that FN induced protooncogenes and cell-
cycle regulatory proteins mediated by signaling pathways
involving RhoA-PI3K/Akt-ERK 1/2 and caveolin-1 in mouse ES
cells [32]. It was recently reported that in mES cells cultured in
feeder-free conditions, fibronectin produced by mES cells or
added to the medium, interacts with the gelatin substrate,
providing a surface that supports cell adhesion and self-
renewal [33].
Previously, it had been shown that the FN isoform that
includes the extra domain A was mitogenic for granulosa cells
[15]. Contrary to plasma FN, which is synthesized in the liver
and lacks this exon, FN EDA+ is highly expressed in embryonic
tissues and inclusion of the EDA domain decreases with aging
[34–36]. FN EDA+ is found in proliferating tissues, wound
healing [17,37] and tissue fibrosis [18,38,39]. It was also
reported that this isoform stimulates keratinocyte
hyperproliferation [40] and lung fibroblast proliferation [41], and
that it is related with tumor malignancy [42–44] and psoriasis
[40]. In addition, it was shown that FN EDA+ induces cyclin D1
expression, pRb hyperphosphorylation, and extracellular signal
regulated kinase 2 activation [19]. These evidences as a whole
strongly support that this isoform is involved in cell proliferation.
In this work we found that FN EDA+ is a mitogenic factor for
mouse and human ESC. We addressed this question by two
different experimental approaches. We provided FN EDA+ or
FN EDA- to ES cells by culturing them in media that was
previously conditioned by genetically modified MEFs only
secreting FN EDA+ or FN- EDA-, or in standard culture medium
with the addition of recombinant peptides containing or not the
EDA. With both approaches we could appreciate the higher
proliferation rate of ES cells cultured in the presence of EDA.
We found a high decrease in proliferation when cells were
cultured in EDA-/- MEF-CM respect to wt MEF-CM or EDA+/+
MEF-CM. As the EDA-/- MEF line does not express FN
containing EDA [23], the lower proliferation rate in cells
cultured with EDA-/- MEF-CM is apparently related to the
absence of EDA-containing FN in the medium. Notably,
although we noticed a slight increase in proliferation in EDA+/+
MEF-CM respect to wt MEF-CM, the differences between
these two conditions were not so pronounced. It is probable
that the levels of FN EDA+ present in wt MEF-CM could be high
enough to promote mES cells proliferation.
Otherwise, mouse and human ES cells endogenously
express EDA containing FN (Figure S3). We hypothesized that
the levels of endogenous EDA modulate the magnitude of the
response to exogenous EDA. We are studying this hypothesis
by modulation of endogenous FN EDA+.
EDA Fibronectin Increases ESC's Proliferation
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Regarding the FN receptors, even though cells normally
express a wide repertoire of integrins, and that they exhibit a
high level of promiscuity of their ligands, the α5/β1 integrin is
considered as the classic FN receptor, since it possesses high
binding-affinity only to this protein [45,46]. Different integrin
receptors have been reported to bind the EDA: the α4β7
integrin partially mediates adhesion to FN EDA+ in murine and
human lung fibroblasts [24], α4β1 was reported as EDA
receptor in human melanoma cells [47], and α9β1 integrin was
also proposed as the FN EDA+ specific receptor in multiple
models [42,47–50]. However, to our knowledge, there is no
evidence so far about the specific FN EDA+ receptor in stem
Figure 3.  FN EDA+ but not FN EDA- increases the proliferation of human ESC.  WAO9 human ES cells were plated in standard
proliferation medium. 24 hours later, when the cells were attached, medium was replaced by fresh medium containing the
corresponding peptide preparation to a final dose of 10 µg of protein per ml of medium. (A) Representative brightfield pictures of the
wound-healing assay. The scratch was made the same day that the peptide was added to the medium. Left panel, linear scratch;
right panel, circular scratch. The references are the same than in Figure 2. Bars correspond to 200 µm. (B) Quantification of the
filled areas of a representative experiment of three replicates. Proliferation was calculated from the decrement in damaged area.
The areas were quantified with the ImageJ software. The filled area in each condition was referred as the amount of filled area in
the control, considered as 100%. The graph is representative of a scratch wound healing assay of three replicates.
doi: 10.1371/journal.pone.0080681.g003
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cells. Further work should be done to determine if the same
receptors and effectors that mediate the different FN EDA+
effects on other cell types are responsible for increasing mouse
and human ES cells’ proliferation rate.
With respect to human ES cells, extracellular matrix proteins
have been extensively studied as scaffold or substrate to both
promote undifferentiated propagation by activation of adhesion
and signaling pathways responsible for their self-renewal [51],
and to direct differentiation [52]. However, to our knowledge
this is the first report showing that a particular soluble FN
isoform increases hES cells’ proliferation when added to the
culture medium.
In summary, we reported that FN EDA+ increases
proliferation in mouse and human ESC. We are currently
studying if the same phenomenon is observed when culturing
iPSCs and the molecular mechanisms involved. Elucidating the
actors implicated in stem cells proliferation would contribute to
the understanding of pluripotent stem cells biology.
Table 2. Analysis of BrdU incorporation in WAO9 hES cells in different media conditions.
 Positive BrdU cells (%) N(1) p value(2)
Control 29,78 943  
EDA+/+ MEF-CM 70,34 1147 <0.001
FN EDA+ Peptide 85,70 1038 <0.001
(1) Number of total cells positive for DAPI staining (2) p values resulted from comparison of each treatment with the control. A Chi Square test was used to compare the
number of positive BrdU cells between control and each treatment. Bonferroni´s method was used to correct p values for multiple comparisons. Control: untreated cells.
Values correspond to a representative experiment with three biological replicates.
doi: 10.1371/journal.pone.0080681.t002
Table 3. Analysis of Ki67 presence in WAO9 hES cells in different media conditions.
 Positive Ki67 cells (%) N(1) p value(2)
Control 19,49 1519  
EDA+/+ MEF-CM 33,80 1284 <0.001
FN EDA+ Peptide 49,26 1011 <0.001
(1) Number of total cells positive for DAPI staining (2) p values resulted from comparison of each treatment with the control. A Chi Square test was used to compare the
number of positive Ki67cells between control and each treatment. Bonferroni´s method was used to correct p values for multiple comparisons. Control: untreated cells.
Values correspond to a representative experiment with three biological replicates.
doi: 10.1371/journal.pone.0080681.t003
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Figure 4.  EDA –treated ES cells express pluripotency markers.  WA09 human ES cells and Ainv15 mouse ES cells were
cultured for three days on feeder free conditions in the indicated medium (untreated cells, C; EDA+/+ MEF-CM, CM; EDA+ including
peptide, PEP). RNA was extracted and the expression of Oct4, Sox2 and Nanog pluripotency gene markers was analyzed by RT-
PCR. The expression of the housekeeping GAPDH gene was used as control.
doi: 10.1371/journal.pone.0080681.g004
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Figure 5.  EDA–treated human ESC can differentiate to the three germ layers.  WA09 hES cells were cultured for three days on
Matrigel coated dishes in the indicated medium (untreated cells, C; EDA+/+ MEF-CM, CM; EDA+ including peptide, PEP) and then in
vitro differentiated as described in Material and Methods Section for seven days. RNA was extracted and the expression of lineage
specific gene markers was analyzed by RT-PCR. Alpha-fetoprotein (AFP), endoderm gene marker; Cardiac Troponin (CT),
mesoderm gene marker; PAX6, ectoderm gene marker.
doi: 10.1371/journal.pone.0080681.g005
Figure 6.  EDA–treated mouse ESC can differentiate to the three germ layers.  Ainv15 mES cells were cultured for three days
on gelatin coated dishes in the presence of EDA+ peptide. Then, 106 cells were injected subcutaneously into nude mice, as
described in Material and Methods Section. Four-micrometer sections from teratoma tissue were stained with hematoxylin and
eosin. (A–C) Representative histology of teratoma (A) Neuroepithelium (arrow, ectoderm) and mesenchymal tissue (star,
mesoderm); (B) Neuroepithelium (arrow, ectoderm) and glial tissue (ectoderm); Glandular tissue (arrow, endoderm).
doi: 10.1371/journal.pone.0080681.g006
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Supporting Information
Figure S1.  Dose-response curve. Ainv15 mES cells were
plated in standard proliferation medium. 24 hours later, when
the cells were attached, medium was replaced by fresh
medium containing the corresponding peptide. (A) Dose-
response curve. ES cells were cultured in the standard media
supplemented by progressive dilutions of EDA-containing or
EDA-lacking recombinant peptide preparations (EDA+ or EDA-,
respectively), as indicated, for 72 hours. Dilution 1 corresponds
to peptide preparation containing 10 µg of protein per ml of
medium. Proliferation was evaluated by crystal violet staining
assay. A representative experiment of at least three replicates
is shown. Data are shown as mean ± SD. Statistical analysis
was done by Two way ANOVA with Bonferroni test for multiple
comparisons. Different uppercase letters indicate significant
differences between dilutions (P < 0.01). Different lowercase
letters indicate significant differences between EDA treatments
(P < 0.001).
(TIF)
Figure S2.  EDA+ but not EDA- peptide increases the
proliferation rate of HUES-5 hESC. HUES-5 human ES cells
were plated in standard proliferation medium. Twenty four
hours later, when the cells were attached, medium was
replaced by fresh medium containing or not (-) the
corresponding peptide preparation to a final dose of 10 µg of
protein per ml of medium; EDA-containing or EDA-lacking
recombinant peptides (EDA+ or EDA-, respectively). (A)
Representative brightfield pictures of the wound-healing assay.
The scratch was made the same day that the peptide was
added to the medium. (B) Quantification of the filled areas of a
representative experiment of three replicates. Proliferation was
calculated from the decrement in damaged area. The areas
were quantified with the ImageJ software. The filled area in
each condition was referred as the amount of filled area in the
control, considered as 100%. The graph is representative of a
scratch wound healing assay of three replicates.
(TIF)
Figure S3.  Mouse and human ES cells express FN EDA+.
WA09 human ES cells and Ainv15 mouse ES cells were
cultured in standard proliferation media. RNA was extracted
and the expression of FN EDA+ was analyzed by RT-PCR. The
expression of the housekeeping GAPDH gene was used as
control.
(TIF)
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